
As April 16 approaches, all eyes are on pharma giant Johnson & Johnson (JNJ), waiting to see if its first-quarter earnings will shake up the Pharmaceutical industry. This article explains why the stock could be an ideal buy now.
Before delving into the reasons, let us first see what is happening in the pharma industry,